搜尋
產品
社群
市場
新聞
經紀商
更多
TW
立即開始
BIOGEN (BIIB)
看多
Biogen Inc.
(
NASDAQ:BIIB
)
mgiuliani
Essential
NASDAQ:BIIB
Biogen Inc.
12
2
We think the company has a above average capital gains return. The comèany has taken a lot of debt, and we belive that that debt will be used soon to make an acquisition. Potential target is Shire Pharma.
相關想法
Standard & Poor's (SPX)
mgiuliani
Essential
about
SPX
8
EURUSD
mgiuliani
Essential
about
EURUSD
1
S&P500 (SPX)
mgiuliani
Essential
about
SPX
5
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款
閱讀更多資訊。